FN2 Earnings Intelligence
Intuitive Surgical, Inc. income statement (quarterly)
Intuitive Surgical, Inc. (ISRG) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 3/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $3,403.1 | $2,806.6 | $2,006.5 | $2,760.4 | $2,978.1 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $2,440 | $2,505.1 | $2,770.8 | $2,892.3 | $3,048.7 | $3,232.9 | $3,119.7 |
| % Growth | - | - | - | - | - | - | 12.6% |
| Gross Profit | $1,617.9 | $1,662.4 | $1,830.5 | $1,960.4 | $2,084.3 | - | - |
| % Margin | 66.3% | 66.4% | 66.1% | 67.8% | 68.4% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $658.4 | $704.4 | $821.5 | $818.1 | $522.8 | - | - |
| % Margin | 27.0% | 28.1% | 29.6% | 28.3% | 17.1% | - | - |
| Diluted EPS | $1.81 | $1.95 | $2.28 | $2.29 | $1.49 | $2.95 | $2.85 |
| % Growth | - | - | - | - | - | - | 24.9% |
| Operating Cash Flow | - | - | $911.9 | - | - | - | - |
| CapEx | - | - | $103.3 | - | - | - | - |
| Free Cash Flow | - | - | $808.6 | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 3/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $2,440 | $2,505.1 | $2,770.8 | $2,892.3 | $3,048.7 | $3,232.9 | $3,119.7 |
| Gross Profit | $1,617.9 | $1,662.4 | $1,830.5 | $1,960.4 | $2,084.3 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $658.4 | $704.4 | $821.5 | $818.1 | $522.8 | - | - |
| Diluted EPS | $1.81 | $1.95 | $2.28 | $2.29 | $1.49 | $2.95 | $2.85 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $3,403.1 | $2,806.6 | $2,006.5 | $2,760.4 | $2,978.1 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $911.9 | - | - |
| Capital Expenditure | - | - | $103.3 | - | - |
| Free Cash Flow | - | - | $808.6 | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 66.3% | 66.4% | 66.1% | 67.8% | 68.4% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 27.0% | 28.1% | 29.6% | 28.3% | 17.1% |
| FCF Margin | - | - | 29.2% | - | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the ISRG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.